| Paul StangAffiliation: Johnson and Johnson Pharmaceutical Research and Development Country: USA Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes PartnershipPaul E Stang Johnson and Johnson Pharmaceutical Research and Development, Titusville, New Jersey 08560, USA Ann Intern Med 153:600-6. 2010 Genome-wide association study for empirically derived metabolic phenotypes in the Framingham Heart Study offspring cohortMarsha Wilcox Epidemiology, Johnson and Johnson Pharmaceutical Research and Development, LLC, 1125 Trenton Harbourton Road, PO Box 200, M S K304, Titusville, New Jersey 08560 USA BMC Proc 3:S53. 2009 Comparison of methods for correcting population stratification in a genome-wide association study of rheumatoid arthritis: principal-component analysis versus multidimensional scalingDai Wang Department of Pharmacogenomics, Johnson and Johnson Pharmaceutical Research and Development, LLC, Raritan, New Jersey 08869 USA BMC Proc 3:S109. 2009
| - Dai Wang
- Yu Sun
- Marsha Wilcox
- Qingqin Li
- Marsha A Wilcox
- Jesse A Berlin
- Jesse Berlin
|